首页> 外文期刊>Water Research >Photocatalytic degradation of non-steroidal anti-inflammatory drugs with TiO_2 and simulated solar irradiation
【24h】

Photocatalytic degradation of non-steroidal anti-inflammatory drugs with TiO_2 and simulated solar irradiation

机译:TiO_2和模拟太阳辐射对非甾体类抗炎药的光催化降解

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this work is to evaluate and compare the degradation achieved for three non-steroidal anti-inflammatory drugs (NSAIDs) by heterogeneous TiO_2 photocatalytic means in aqueous solution at laboratory scale. The selected pharmaceutical compounds were diclofenac (DCF), naproxen (NPX) and ibuprofen (IBP). These compounds were used in their sodium salt chemical form. Previous experiments (adsorption, photolysis and thermodegradation) were developed to evaluate non-catalytic degradation for each NSAID. Photocatalytic experiments were carried out in a Xe-lamp reactor in order to study the influences of different operational conditions (catalyst load, temperature and dissolved oxygen concentration). These results showed that the optimum amount of TiO_2, to achieve maximum degradation, of IBP was 1 g/L. In contrast, the maximum degradation for DCF or NPX was observed at a TiO_2 loading of 0.1 g/L. Temperature had a significant effect only for NPX degradation, achieving almost 99% phototransformation. No significant differences were observed for DCF and IBP at 20, 30 and 40 ℃. Dissolved oxygen concentration was an important parameter to increase the degradation for NPX and IBP. However, it was observed that its rate of mineralization did not increase. Intermediate metabolites were detected in all cases. Hydroxyl metabolites were the most important residual compounds after the photocatalytic treatment of IBP. The inhibition percentage of bioluminescence from Vibro fischeri-as a toxicity parameter-increased during the irradiation time due to the residual concentration of the hydroxyl metabolites generated. However, after 120 min, in experiments with 40 mg/L of dissolved oxygen, a decrease of the % inhibition was observed. Only photocatalytic treatment of IBP drives to a satisfactory biodegradability index BOD_5/COD (between 0.16 and 0.42) and, only in this case, a post-biological treatment could be suggested.
机译:这项工作的目的是在实验室规模上评估和比较通过非均相TiO_2光催化方法在水溶液中对三种非甾体类抗炎药(NSAID)的降解。选择的药物化合物是双氯芬酸(DCF),萘普生(NPX)和布洛芬(IBP)。这些化合物以其钠盐化学形式使用。已经开发了先前的实验(吸附,光解和热降解)来评估每种NSAID的非催化降解。为了研究不同操作条件(催化剂负载,温度和溶解氧浓度)的影响,在Xe灯反应器中进行了光催化实验。这些结果表明,为了实现最大降解,最佳的TiO_2量为1 g / L。相比之下,在0.1 g / L的TiO_2负载下观察到DCF或NPX的最大降解。温度仅对NPX降解有重大影响,实现了近99%的光转化。 DCF和IBP在20、30和40℃时没有观察到显着差异。溶解氧浓度是增加NPX和IBP降解的重要参数。但是,观察到其矿化速率没有增加。在所有情况下均检测到中间代谢物。在IBP的光催化处理之后,羟基代谢物是最重要的残留化合物。由于产生的羟基代谢物的残留浓度,在辐照时间内,来自费氏弧菌的生物发光的抑制百分比(作为毒性参数)增加了。但是,在120分钟后,在使用40 mg / L溶解氧的实验中,观察到抑制百分率降低。只有IBP的光催化处理才能达到令人满意的生物降解指数BOD_5 / COD(介于0.16和0.42之间),并且只有在这种情况下,才建议进行生物后处理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号